 RAMSEY, N.J. and BOCA RATON, Fla., Nov. 10, 2020 GLOBE NEWSWIRE -- ADMA Biologics, Inc. Nasdaq: ADMA ADMA or the Company, an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that Adam Grossman, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies 2020 Virtual London Healthcare Conference on Tuesday, November 17, 2020, at 7:55 a.m. ET. 